| 000 | 01905 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517135902.0 | ||
| 264 | 0 | _c20171222 | |
| 008 | 201712s 0 0 eng d | ||
| 022 | _a1537-6591 | ||
| 024 | 7 |
_a10.1093/cid/ciw803 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCowan, James F | |
| 245 | 0 | 0 |
_aClinical Impact and Cost-effectiveness of Xpert MTB/RIF Testing in Hospitalized Patients With Presumptive Pulmonary Tuberculosis in the United States. _h[electronic resource] |
| 260 |
_bClinical infectious diseases : an official publication of the Infectious Diseases Society of America _c02 2017 |
||
| 300 |
_a482-489 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aDNA, Bacterial |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHospitalization |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _xgenetics |
| 650 | 0 | 4 |
_aNucleic Acid Amplification Techniques _xeconomics |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 |
_aSputum _xmicrobiology |
| 650 | 0 | 4 |
_aTuberculosis, Pulmonary _xdiagnosis |
| 650 | 0 | 4 | _aWashington |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aChandler, Aldine S | |
| 700 | 1 | _aKracen, Elizabeth | |
| 700 | 1 | _aPark, David R | |
| 700 | 1 | _aWallis, Carolyn K | |
| 700 | 1 | _aLiu, Emelline | |
| 700 | 1 | _aSong, Chao | |
| 700 | 1 | _aPersing, David H | |
| 700 | 1 | _aFang, Ferric C | |
| 773 | 0 |
_tClinical infectious diseases : an official publication of the Infectious Diseases Society of America _gvol. 64 _gno. 4 _gp. 482-489 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/cid/ciw803 _zAvailable from publisher's website |
| 999 |
_c26858904 _d26858904 |
||